Yiting Jin
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Research and Splicing
- Circular RNAs in diseases
Papers in
-
- RNA modifications and cancer 5
- RNA Research and Splicing 3
- Epigenetics and DNA Methylation 3
-
- Cancer-related molecular mechanisms research 4
- Breast Cancer Treatment Studies 3
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Qiang Zou (17 shared papers)Xiuping Liu (10 shared papers)Lei Xu (1 shared paper)Chengyu Chu (11 shared papers)Shengming Sun (4 shared papers)Hongying Wang (8 shared papers)Xiaotao Shi (1 shared paper)Yun Cao (7 shared papers)
- Journals
- Journal of Cancer (2 papers)International Journal of Genomics (2 papers)Oncogene (2 papers)Molecular Oncology (1 paper)Molecular Carcinogenesis (1 paper)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Yiting Jin
32 papers receiving 753 citations
Peers
Comparison fields: 5 of 102
- Cancer Research 209
- Molecular Biology 438
- Physiology 27
- Pollution 62
- Oncology 132
Countries citing papers authored by Yiting Jin
This map shows the geographic impact of Yiting Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiting Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiting Jin more than expected).
Fields of papers citing papers by Yiting Jin
This network shows the impact of papers produced by Yiting Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiting Jin. The network helps show where Yiting Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Yiting Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 99 | |
| 2 | 2022 | 65 | |
| 3 | 2016 | 63 | |
| 4 | 2017 | 61 | |
| 5 | 2016 | 48 | |
| 6 | 2021 | 46 | |
| 7 | 2013 | 44 | |
| 8 | 2020 | 38 | |
| 9 | 2015 | 34 | |
| 10 | UCH-L1 involved in regulating the degradation of EGFR and promoting malignant properties in drug-resistant breast cancer. | 2015 | 33 |
| 11 | 2017 | 31 | |
| 12 | 2016 | 28 | |
| 13 | 2020 | 26 | |
| 14 | Association between molecular subtypes and lymph node status in invasive breast cancer. | 2014 | 24 |
| 15 | 2021 | 18 | |
| 16 | 2019 | 11 | |
| 17 | 2008 | 11 | |
| 18 | 2022 | 10 | |
| 19 | 2022 | 9 | |
| 20 | Prognostic value of epithelial-mesenchymal transition related genes: SLUG and QKI in breast cancer patients. | 2019 | 9 |
About Yiting Jin
Yiting Jin is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine, having authored 34 papers that have together received 761 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers), Cancer Cells and Metastasis (3 papers), RNA Research and Splicing (3 papers), Breast Cancer Treatment Studies (3 papers), Epigenetics and DNA Methylation (3 papers), Ferroptosis and cancer prognosis (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (209 citations), Molecular Biology (438 citations), Physiology (27 citations), Pollution (62 citations) and Oncology (132 citations). Yiting Jin has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Qiang Zou, Xiuping Liu, Lei Xu, Chengyu Chu, Shengming Sun, Hongying Wang, Xiaotao Shi, Yun Cao, Di Ding and Xiaoyan Li. Their work appears in journals such as Journal of Cancer, International Journal of Genomics, Oncogene, Molecular Oncology and Molecular Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.